Works matching DE "LAMIVUDINE"
Results: 1073
Outcomes of HIV-infected children on antiretroviral therapy for at least 10 years at the Essos Hospital Centre, Cameroon: contributing to the elimination of paediatric AIDS in tropical settings.
- Published in:
- Journal of Tropical Pediatrics, 2025, v. 71, n. 1, p. 1, doi. 10.1093/tropej/fmae052
- By:
- Publication type:
- Article
Non-Hodgkin Lymphoma.
- Published in:
- Current Medical Literature: Leukemia & Lymphoma, 2009, v. 17, n. 4, p. 110
- Publication type:
- Article
Centrosome Amplification Induced by the Antiretroviral Nucleoside Reverse Transcriptase Inhibitors Lamivudine, Stavudine, and Didanosine.
- Published in:
- Environmental & Molecular Mutagenesis, 2009, v. 50, n. 8, p. 718, doi. 10.1002/em.20509
- By:
- Publication type:
- Article
Survival of infantile fulminant hepatitis B and treatment with Lamivudine.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Hepatitis B Management in the Middle East: A Narrative Review of Current Antiviral Treatments.
- Published in:
- Gastrointestinal Disorders, 2024, v. 6, n. 3, p. 784, doi. 10.3390/gidisord6030054
- By:
- Publication type:
- Article
Selenium Protects against Tenofovir/Lamivudine/Efavirenz-Induced Nephrotoxicity in Rats.
- Published in:
- Journal of Nature & Science of Medicine, 2022, v. 5, n. 2, p. 157, doi. 10.4103/jnsm.jnsm_153_20
- By:
- Publication type:
- Article
Descriptive analysis of adverse drug reactions to antiretroviral therapy: Causality, severity, and preventability assessment at a tertiary care teaching hospital.
- Published in:
- International Journal of Academic Medicine, 2022, v. 8, n. 1, p. 4, doi. 10.4103/IJAM.IJAM_1_21
- By:
- Publication type:
- Article
Demonstration of mutations conferring resistance to lamivudine in liver tissue of chronic hepatitis B patients under lamivudine therapy.
- Published in:
- Turkish Journal of Medical Sciences, 2013, v. 43, n. 2, p. 199, doi. 10.3906/sag-1108-16
- By:
- Publication type:
- Article
Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2015, v. 34, n. 3, p. 619, doi. 10.1007/s10096-014-2270-0
- By:
- Publication type:
- Article
Lamivudine versus telbivudine in the treatment of chronic hepatitis B: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2013, v. 32, n. 1, p. 11, doi. 10.1007/s10096-012-1723-6
- By:
- Publication type:
- Article
The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2012, v. 31, n. 9, p. 2211, doi. 10.1007/s10096-012-1557-2
- By:
- Publication type:
- Article
Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2010, v. 29, n. 7, p. 779, doi. 10.1007/s10096-010-0926-y
- By:
- Publication type:
- Article
Author Correction: Pcyt2 deficiency causes age-dependent development of nonalcoholic steatohepatitis and insulin resistance that could be attenuated with phosphoethanolamine.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36725-w
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 8, p. 1877, doi. 10.1007/s40121-024-01008-y
- By:
- Publication type:
- Article
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 891, doi. 10.1007/s40121-024-00961-y
- By:
- Publication type:
- Article
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 875, doi. 10.1007/s40121-024-00950-1
- By:
- Publication type:
- Article
Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 11, p. 2581, doi. 10.1007/s40121-023-00879-x
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of Ainuovirine/Lamivudine/Tenofovir Combination Tablets in Young and Elderly Patients with Human Immunodeficiency Virus-1 Infection.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 10, p. 2457, doi. 10.1007/s40121-023-00877-z
- By:
- Publication type:
- Article
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 8, p. 2117, doi. 10.1007/s40121-023-00848-4
- By:
- Publication type:
- Article
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 3, p. 1177, doi. 10.1007/s40121-022-00630-y
- By:
- Publication type:
- Article
HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.
- Published in:
- Infectious Diseases & Therapy, 2021, v. 10, n. 4, p. 2051, doi. 10.1007/s40121-021-00522-7
- By:
- Publication type:
- Article
Weight‐adapted fixed‐dose combined adult antiretroviral tablets for HIV‐infected children.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 4, p. 867, doi. 10.1111/jcpt.13341
- By:
- Publication type:
- Article
DNA Engineering and Hepatitis B Virus Replication.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.783040
- By:
- Publication type:
- Article
E2 Site Mutations in S Protein Strongly Affect Hepatitis B Surface Antigen Detection in the Occult Hepatitis B Virus.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.664833
- By:
- Publication type:
- Article
STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.663534
- By:
- Publication type:
- Article
Difluoromethylornithine, a Decarboxylase 1 Inhibitor, Suppresses Hepatitis B Virus Replication by Reducing HBc Protein Levels.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. 1, doi. 10.3389/fcimb.2020.00158
- By:
- Publication type:
- Article
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 39, n. 1, p. 35, doi. 10.1111/apt.12538
- By:
- Publication type:
- Article
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 98, doi. 10.1111/apt.12344
- By:
- Publication type:
- Article
Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 12, p. 1482, doi. 10.1111/j.1365-2036.2012.05105.x
- By:
- Publication type:
- Article
Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 9, p. 1027, doi. 10.1111/j.1365-2036.2012.05059.x
- By:
- Publication type:
- Article
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 6, p. 674, doi. 10.1111/j.1365-2036.2011.04990.x
- By:
- Publication type:
- Article
Meta-analysis: antiviral treatment for hepatitis D.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 6, p. 663, doi. 10.1111/j.1365-2036.2012.04993.x
- By:
- Publication type:
- Article
Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 8, p. 972, doi. 10.1111/j.1365-2036.2011.04833.x
- By:
- Publication type:
- Article
The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 7, p. 767, doi. 10.1111/j.1365-2036.2011.04785.x
- By:
- Publication type:
- Article
Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 4, p. 424, doi. 10.1111/j.1365-2036.2011.04750.x
- By:
- Publication type:
- Article
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 344, doi. 10.1111/j.1365-2036.2011.04738.x
- By:
- Publication type:
- Article
Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 1, p. 105, doi. 10.1111/j.1365-2036.2011.04689.x
- By:
- Publication type:
- Article
Evaluation of antibacterial activity and osteoblast-like cell viability of TiN, ZrN and (Ti<sub>1-x</sub>Zr<sub>x</sub>) N coating on titanium.
- Published in:
- Journal of Advanced Prosthodontics, 2015, v. 7, n. 2, p. 166, doi. 10.4047/jap.2015.7.2.166
- By:
- Publication type:
- Article
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis.
- Published in:
- Infection & Chemotherapy, 2024, v. 56, n. 3, p. 395, doi. 10.3947/ic.2024.0066
- By:
- Publication type:
- Article
A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1.
- Published in:
- Infection & Chemotherapy, 2023, v. 55, n. 3, p. 337, doi. 10.3947/ic.2022.0176
- By:
- Publication type:
- Article
LONG-TERM INTEGRATED ANALYSIS OF B/F/TAF IN TREATMENT-NAÏVE ADULTS WITH HIV THROUGH FIVE YEARS OF FOLLOW-UP.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 283
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine (DTG/3TC) in Treatment-Experienced, Virologically Suppressed PLHIV Aged ≥50 Years: Pooled Results From the TANGO and SALSA Studies.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 273
- By:
- Publication type:
- Article
Changes in Inflammatory Biomarkers and Baseline Variables After Switching to Dolutegravir/Lamivudine(DTG/3TC) in 2 Randomized Clinical Trials of Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 272
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine by Baseline Regimen in Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 271
- By:
- Publication type:
- Article
Lamivudine/Tenofovir Disoproxil Fumarate is an Appropriate PrEP Regimen.
- Published in:
- Drugs, 2020, v. 80, n. 18, p. 1881, doi. 10.1007/s40265-020-01419-4
- By:
- Publication type:
- Article
Dolutegravir/Lamivudine Single-Tablet Regimen: A Review in HIV-1 Infection.
- Published in:
- Drugs, 2020, v. 80, n. 1, p. 61, doi. 10.1007/s40265-019-01247-1
- By:
- Publication type:
- Article
Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
- Published in:
- Drugs, 2018, v. 78, n. 17, p. 1817, doi. 10.1007/s40265-018-1010-7
- By:
- Publication type:
- Article
Doravirine: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 15, p. 1643, doi. 10.1007/s40265-018-0993-4
- By:
- Publication type:
- Article
Virologic response and breakthrough in chronic hepatitis B Egyptian patients receiving lamivudine therapy.
- Published in:
- Annals of Gastroenterology, 2014, v. 27, n. 4, p. 380
- By:
- Publication type:
- Article
Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion.
- Published in:
- Scandinavian Journal of Gastroenterology, 2010, v. 45, n. 1, p. 75, doi. 10.3109/00365520903394550
- By:
- Publication type:
- Article